Coverart for item
The Resource The tumor immunoenvironment, Michael R. Shurin, Viktor Umansky, Anatoli Malyguine, editors

The tumor immunoenvironment, Michael R. Shurin, Viktor Umansky, Anatoli Malyguine, editors

Label
The tumor immunoenvironment
Title
The tumor immunoenvironment
Statement of responsibility
Michael R. Shurin, Viktor Umansky, Anatoli Malyguine, editors
Contributor
Subject
Language
eng
Summary
Analysis of multidirectional immunological responses at the tumor site allows forming a new concept of The Tumor Immunoenvironment, which is introduced and discussed in the present book with a particular focus on the role of immune cells in controlling the tumor microenvironment at different stages of cancer development. The main goal of this publication is to provide an overview of the current knowledge on the complex and unique role of the immune system, tumor-associated inflammation and tumor-mediated immunomodulation in cancer progression in a way that allows understanding the logistics of cellular and molecular interactions in the tumor lesions
Member of
Cataloging source
GW5XE
Dewey number
616.99
Index
index present
LC call number
QR188.6
LC item number
.T86 2013
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
NLM call number
QZ 200
http://library.link/vocab/relatedWorkOrContributorName
  • Shurin, Michael R
  • Umansky, Viktor
  • Malyguine, Anatoli
http://library.link/vocab/subjectName
  • Tumors
  • Tumors
  • Neoplasms
  • Neoplasms
  • HEALTH & FITNESS
  • MEDICAL
  • MEDICAL
  • MEDICAL
  • MEDICAL
  • Tumors
  • Tumors
  • Biomedicine
  • Cancer Research
  • Oncology
  • Immunology
  • Life Sciences, general
  • Biomedicine general
Label
The tumor immunoenvironment, Michael R. Shurin, Viktor Umansky, Anatoli Malyguine, editors
Instantiates
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • T Cell Mulfunction in the Tumor Environment
  • Eitan Yefenof
  • Signaling of Tumor-Induced Immunosuppression of Dendritic Cells
  • Yong Lu, Jing Yang, Qing Yi
  • Tumor Microenvironment may Shape the Function and Phenotype of NK Cells Through the Induction of Split Anergy and Generation of Regulatory NK Cells
  • Anahid Jewett, Han-Ching Tseng
  • Tumor Escape from Immune Recognition.
  • MHC Class I Antigens and the Tumor Microenvironment
  • Natalia Aptsiauri [and others]
  • Tumor-Produced Immune Regulating Factors
  • Mads Hald Andersen, Jürgen C. Becker, Per thor Straten
  • Roles of Signaling Pathways in Cancer Cells and Immune Cells in Generation of Immunosuppressive Tumor-Associated Microenvironments
  • Yutaka Kawakami [and others]
  • Zvi G. Fridlender
  • Mast Cell Modulation of the Tumor Microenvironment
  • Sharon A. Oldford, Jean S. Marshall
  • Regulatory T Cells in Patients with Cancer
  • Theresa L. Whiteside
  • Tumor-Evoked Regulatory B Cells as Important Mediators of Cancer Escape
  • Catalina Lee-Chang, Monica Bodogai, Arya Biragyn
  • Immune Regulators in the Tumor Immunoenvironment.
  • The Role of Myeloid Derived Suppressor Cells in Cancer
  • Jonathan M. Weiss
  • Macrophage Differentiation and Activation States in the Tumor Microenvironment
  • Jo A. Van Ginderachter
  • Dendritic Cells and Cancer: Development, Dysfunction and Therapeutic Targets
  • Stephanie K. Watkins, Arthur A. Hurwitz
  • The Role of Tumor Associated Neutrophils in Cancer
  • Michael R. Shurin, Viktor Umansky
  • Combining Vaccines with Therapies that Render Tumor Cells more Susceptible to Immune Mediated Killing
  • Nishith Singh [and others]
  • Prophylactic Cancer Vaccines
  • Pamela L. Beatty, Olivera J. Finn
  • Analyzing Immune Responses in Cancer.
  • Approaches to Immunologic Monitoring of Clinical Trials
  • Lisa H. Butterfield, Lazar Vujanovic, Angela D. Pardee
  • Evaluation of the Tumor Immunoenvironment in Clinical Trials
  • Anatoli Malyguine [and others]
  • Tumor Escape and Cancer Immunotherapy.
  • Analysis of Myeloid-Derived Suppressor Cells in Patients with Cancer
  • Peiyuan Zhu [and others]
  • When Results of T cell Immune Monitoring Match/Do Not Match Clinical Outcomes of Tumor Vaccine Trials: What More Could and Should We Measure?
  • Paul V. Lehmann, Srividya Sundararaman
  • Cancer Immunotherapy: Overview in Brief
  • Philipp Beckhove
  • Programming of MDSC: New Opportunities for Targeted Therapy
  • Peter Svider [and others]
  • Therapeutic Targeting Regulatory T Cells in Tumor
  • Wei Wang, Weiping Zou
  • ChemoImmunoModulation: Focus on Myeloid Regulatory Cells
  • 1. Role of the immunological environment in cancer initiation, development and progression -- 2. The metastatic microenvironment -- 3. Tumor infiltration by immune cells: pathologic evaluation and a clinical significance -- 4. Immunologic interpretation of cancer biology: impact on clinical outcome -- 5. Development of antitumor cellular immunity -- 6. The versatile world of inflammatory chemokines in cancer -- 7. Inflammation, tumor progression, and immune suppression -- 8. Pleiotropic and differential functions of IL-1 alpha and IL-1 beta shape the tumor microenvironment and affect the outcome of malignancies -- 9. Impact of obesity and aging on the tumor immuno-environment -- 10. MHC class I antigens and the tumor microenvironment -- 11. Tumor-produced immune regulating factors -- 12. Roles of signaling pathways in cancer cells and immune cells in generation of immunosupressive tumor-associated microenvironments -- 13. T cell mulfunction in the tumor environment -- 14. Signaling of tumor-induced immunosuppression of dendritic cells -- 15. Tumor microenviroment may shape the funtion and phenotype of NK cells through the induction of split anergy and generation of regulatory NK cells -- 16. The roll of myeloid derived supporessor cells in cancer -- 17. Macrophage differentiation and activation states in the tumor microenvironment -- 18. Dendritic cells and cancer: development, dysfunction and therapeutic targets -- 19. The role of tumor associated neutrphils in cancers -- 20. Mast cell modulation of the microenvironment -- 21. Regulatory T cells in patients with cancer -- 22. Tumor-evoked regulatory B cells as important mediators of cancer escape -- 23. Cancer immunotherapy: overview in brief -- 24. Programming of MDSCMDSC: new opportunities for targeted therapy -- 25. Therapeutic targeting regulatory T cells in tumor -- 26. ChemoImmunoModulation: focus on myeloid regulatory cells -- 27. Combining vaccines with therapies that render tumor cells more susceptible to immune mediated killing -- 28. Prophylactic cancer vaccines -- 29. Approaches to immunologic monitoring of clinical trials -- 30. Evaluation of the tumor immunoenvironment in clinical trials -- 31. Analysis of myeloid-derived suppressor cells in patients with cancer -- 32. When results of T cell immune monitoring match/do not match clinical outcomes of tumor vaccine trials: what more could and should we measure?
Control code
833137657
Dimensions
unknown
Extent
1 online resource
File format
unknown
Form of item
online
Isbn
9789400762176
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other control number
10.1007/978-94-007-6217-6
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
(OCoLC)833137657
Label
The tumor immunoenvironment, Michael R. Shurin, Viktor Umansky, Anatoli Malyguine, editors
Publication
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • T Cell Mulfunction in the Tumor Environment
  • Eitan Yefenof
  • Signaling of Tumor-Induced Immunosuppression of Dendritic Cells
  • Yong Lu, Jing Yang, Qing Yi
  • Tumor Microenvironment may Shape the Function and Phenotype of NK Cells Through the Induction of Split Anergy and Generation of Regulatory NK Cells
  • Anahid Jewett, Han-Ching Tseng
  • Tumor Escape from Immune Recognition.
  • MHC Class I Antigens and the Tumor Microenvironment
  • Natalia Aptsiauri [and others]
  • Tumor-Produced Immune Regulating Factors
  • Mads Hald Andersen, Jürgen C. Becker, Per thor Straten
  • Roles of Signaling Pathways in Cancer Cells and Immune Cells in Generation of Immunosuppressive Tumor-Associated Microenvironments
  • Yutaka Kawakami [and others]
  • Zvi G. Fridlender
  • Mast Cell Modulation of the Tumor Microenvironment
  • Sharon A. Oldford, Jean S. Marshall
  • Regulatory T Cells in Patients with Cancer
  • Theresa L. Whiteside
  • Tumor-Evoked Regulatory B Cells as Important Mediators of Cancer Escape
  • Catalina Lee-Chang, Monica Bodogai, Arya Biragyn
  • Immune Regulators in the Tumor Immunoenvironment.
  • The Role of Myeloid Derived Suppressor Cells in Cancer
  • Jonathan M. Weiss
  • Macrophage Differentiation and Activation States in the Tumor Microenvironment
  • Jo A. Van Ginderachter
  • Dendritic Cells and Cancer: Development, Dysfunction and Therapeutic Targets
  • Stephanie K. Watkins, Arthur A. Hurwitz
  • The Role of Tumor Associated Neutrophils in Cancer
  • Michael R. Shurin, Viktor Umansky
  • Combining Vaccines with Therapies that Render Tumor Cells more Susceptible to Immune Mediated Killing
  • Nishith Singh [and others]
  • Prophylactic Cancer Vaccines
  • Pamela L. Beatty, Olivera J. Finn
  • Analyzing Immune Responses in Cancer.
  • Approaches to Immunologic Monitoring of Clinical Trials
  • Lisa H. Butterfield, Lazar Vujanovic, Angela D. Pardee
  • Evaluation of the Tumor Immunoenvironment in Clinical Trials
  • Anatoli Malyguine [and others]
  • Tumor Escape and Cancer Immunotherapy.
  • Analysis of Myeloid-Derived Suppressor Cells in Patients with Cancer
  • Peiyuan Zhu [and others]
  • When Results of T cell Immune Monitoring Match/Do Not Match Clinical Outcomes of Tumor Vaccine Trials: What More Could and Should We Measure?
  • Paul V. Lehmann, Srividya Sundararaman
  • Cancer Immunotherapy: Overview in Brief
  • Philipp Beckhove
  • Programming of MDSC: New Opportunities for Targeted Therapy
  • Peter Svider [and others]
  • Therapeutic Targeting Regulatory T Cells in Tumor
  • Wei Wang, Weiping Zou
  • ChemoImmunoModulation: Focus on Myeloid Regulatory Cells
  • 1. Role of the immunological environment in cancer initiation, development and progression -- 2. The metastatic microenvironment -- 3. Tumor infiltration by immune cells: pathologic evaluation and a clinical significance -- 4. Immunologic interpretation of cancer biology: impact on clinical outcome -- 5. Development of antitumor cellular immunity -- 6. The versatile world of inflammatory chemokines in cancer -- 7. Inflammation, tumor progression, and immune suppression -- 8. Pleiotropic and differential functions of IL-1 alpha and IL-1 beta shape the tumor microenvironment and affect the outcome of malignancies -- 9. Impact of obesity and aging on the tumor immuno-environment -- 10. MHC class I antigens and the tumor microenvironment -- 11. Tumor-produced immune regulating factors -- 12. Roles of signaling pathways in cancer cells and immune cells in generation of immunosupressive tumor-associated microenvironments -- 13. T cell mulfunction in the tumor environment -- 14. Signaling of tumor-induced immunosuppression of dendritic cells -- 15. Tumor microenviroment may shape the funtion and phenotype of NK cells through the induction of split anergy and generation of regulatory NK cells -- 16. The roll of myeloid derived supporessor cells in cancer -- 17. Macrophage differentiation and activation states in the tumor microenvironment -- 18. Dendritic cells and cancer: development, dysfunction and therapeutic targets -- 19. The role of tumor associated neutrphils in cancers -- 20. Mast cell modulation of the microenvironment -- 21. Regulatory T cells in patients with cancer -- 22. Tumor-evoked regulatory B cells as important mediators of cancer escape -- 23. Cancer immunotherapy: overview in brief -- 24. Programming of MDSCMDSC: new opportunities for targeted therapy -- 25. Therapeutic targeting regulatory T cells in tumor -- 26. ChemoImmunoModulation: focus on myeloid regulatory cells -- 27. Combining vaccines with therapies that render tumor cells more susceptible to immune mediated killing -- 28. Prophylactic cancer vaccines -- 29. Approaches to immunologic monitoring of clinical trials -- 30. Evaluation of the tumor immunoenvironment in clinical trials -- 31. Analysis of myeloid-derived suppressor cells in patients with cancer -- 32. When results of T cell immune monitoring match/do not match clinical outcomes of tumor vaccine trials: what more could and should we measure?
Control code
833137657
Dimensions
unknown
Extent
1 online resource
File format
unknown
Form of item
online
Isbn
9789400762176
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other control number
10.1007/978-94-007-6217-6
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
(OCoLC)833137657

Library Locations

    • Ellis LibraryBorrow it
      1020 Lowry Street, Columbia, MO, 65201, US
      38.944491 -92.326012
Processing Feedback ...